Single Institution Trial Comparing Whole Blood vs Balanced Component Therapy: 50 Years Later
- 18 December 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 232 (4), 433-442
- https://doi.org/10.1016/j.jamcollsurg.2020.12.006
Abstract
Background Early close ratio transfusion with balanced component therapy (BCT) has been associated with improved outcomes in patients with severe hemorrhage; however, this modality is not comparable with whole blood (WB) constituents. We compared use of BCT vs WB to determine if one yielded superior outcomes in patients with severe hemorrhage. We hypothesized that WB would lead to reduced in-hospital mortality and blood product volume if given in the first 24 hours of admission. Study design This was a 1-year, single institution, prospective, observational study comparing BCT with WB in adult (18+y) trauma patients with active hemorrhage who required blood transfusion upon arrival at the emergency department. Primary endpoint was in-hospital mortality. Secondary endpoints included 24-hour transfusion volumes, in-hospital clinical outcomes, and complications. Results A total of 253 patients were included; 71.1% received BCT and 29.9% WB. The WB cohort had significantly more penetrating trauma (64.4% vs 48.9%; p = 0.03) and higher Shock Index (1.12 vs 0.92; p = 0.04). WB patients received significantly fewer units of packed red blood cells (PRBCs) (p < 0.001) and fresh frozen plasma (FFP) (p = 0.04), with a lower incidence of ARDS (p = 0.03) and fewer ventilator days (p = 0.03). Kaplan Meier survival analysis revealed no difference in survival between the 2 transfusion strategies (p = 0.80). When adjusted for various markers of injury severity and critical illness in Cox regression analysis, WB remained unassociated with mortality (hazard ratio 1.25; 95% CI 0.60–2.58; p = 0.55). Conclusions There was no difference in survival rates when comparing BCT with WB. In the WB group, the incidence of ARDS, duration of mechanical ventilation, massive transfusion protocol (MTP) activation, and transfusion volumes were significantly reduced. Further research should be directed at analyzing whether there is a true hemorrhage-related pathophysiologic benefit of WB when compared with BCT.Keywords
This publication has 37 references indexed in Scilit:
- A Randomized Controlled Pilot Trial of Modified Whole Blood versus Component Therapy in Severely Injured Patients Requiring Large Volume TransfusionsAnnals of Surgery, 2013
- The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) StudyJAMA Surgery, 2013
- Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME)Transfusion, 2010
- Warm Fresh Whole Blood Is Independently Associated With Improved Survival for Patients With Combat-Related Traumatic InjuriesThe Journal of Trauma and Acute Care Surgery, 2009
- Acute lung injury following blood transfusion: Expanding the definitionCritical Care Medicine, 2008
- Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applicationsCritical Care Medicine, 2008
- Massive Transfusion in Trauma Patients: Tissue Hemoglobin Oxygen Saturation Predicts Poor OutcomeThe Journal of Trauma and Acute Care Surgery, 2008
- Impact of Hemorrhage on Trauma Outcome: An Overview of Epidemiology, Clinical Presentations, and Therapeutic ConsiderationsThe Journal of Trauma and Acute Care Surgery, 2006
- Management of the Major Coagulopathy with Onset during LaparotomyAnnals of Surgery, 1983
- Whole Blood Versus Packed-cell TransfusionsAnnals of Surgery, 1981